Delivery Order SPE2DB25D3201-SPE2DB25FNTQA

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,053.85 firm-fixed-price contract is for the delivery of CEFAZOLIN 1 G/50 ML-DEXTROSES, a pharmaceutical product, with a performance period extending through June 5, 2025. The award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,228.56 firm fixed-price delivery order is for the medical supply item "CEFAZOLIN 2 G/50 ML-DEXTROSES" and has a completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.52 firm-fixed-price delivery order is for the supply of CEFAZOLIN 1 G/50 ML-DEXTROSES, a medical product, with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.46 Firm Fixed Price contract is for the delivery of 4559987649 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical pharmaceutical product used for medical treatment. The contract has a completion date of February 21, 2023 and was awarded on February 17, 2023. This delivery order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a ceiling value of $6,142.80. The contract is a firm-fixed-price type, with a period of performance ending on May 19, 2025. The contract was awarded on May 16, 2025 and is not set aside for any particular business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a ceiling value of $1,228.56 and a period of performance through May 19, 2025. The contract is not set aside and was awarded on a firm fixed price basis. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a ceiling value of $1,312.96 and a period of performance through January 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.56 contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical antibiotic medication, to support federal healthcare programs. The award is not designated as a set-aside and represents a direct delivery order under Amerisourcebergen's $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,537.95, is a Firm Fixed Price Delivery Order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and was awarded on January 22, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award, valued at $1,445.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565584696 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical medical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTQA
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,808.38 contract is for the delivery of CEFAZOLIN 1 G/50 ML-DEXTROSES, a medication, to be completed by June 4, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is likely part of the company's broader support for federal medical procurement needs, particularly for the military and veteran healthcare systems.

Generated 9/2/25, 9:46 AM